Financials
- Market Capitalization 15.3 M
- Employee 18
- Founded 2017
- CEO N/A
- Website vyometx.com
- Headquarter Delaware, United States
- FIGI BBG0036S6JY0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.71
Relación precio/flujo de caja
23.26
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4697 | CYCN Cyclerion Therapeutics, Inc. - Common Stock | 3.85 USD | -0.77% | +10.63% | +16.31% | +18.46% | 16.67 M USD | ||
| 4704 | AKTX Akari Therapeutics Plc - American Depositary Shares | 13.19 USD | -1.57% | -14.79% | -1.93% | +1088.29% | 15.10 M USD | ||
| 4711 | QNCX Quince Therapeutics, Inc. - Common Stock | 19.98 USD | +15.83% | +12.63% | +2048.39% | +1003.87% | 16.28 M USD | ||
| 4722 | LEXX Lexaria Bioscience Corp. - Common Stock | 0.59 USD | 0.00% | +7.27% | -1.67% | -29.76% | 14.62 M USD |